Navigation Links
Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
Date:3/17/2008

ter of this year."

About RDEA806

RDEA806 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) for the potential treatment of HIV infection. Based on preclinical and clinical studies to-date, Ardea believes that RDEA806 may have important competitive advantages. These include the potential for potent antiviral activity against a wide range of HIV viral isolates, including those that are resistant to efavirenz (SUSTIVA(R)) and other currently available NNRTIs; a high genetic barrier to resistance; the potential to be administered in a patient-friendly, oral dosing regimen; limited pharmacokinetic interactions with other drugs; and the ability to be co-formulated with other HIV antiviral drugs.

Conference Call Details

To participate in tomorrow's live call by telephone, please dial 877-440-5786 from the U.S. or +1-719-325-4862 for international callers. In addition, the live conference call is being webcast and can be accessed on the "News & Events" page of the Company's website at http://www.ardeabio.com. A replay will also be available on Ardea's website and by telephone for 14 days following the live presentation. In the U.S., please dial 888-203-1112 or +1-719-457-0820 for international callers and, when prompted, enter passcode 8779421.

About Ardea Biosciences, Inc.

Ardea Biosciences, of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout. The Company has two product candidates in clinical development and several others in preclinical development. Ardea's most advanced clinical development candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which is in a Phase 2a study for the treatment of HIV. In addition, the Company is investigating RDEA806 for the treatment of gout. The Company's lead
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
2. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
7. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
10. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
11. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis Pharma ... stage biotechnology company that applies its innovative ... needs, today announced plans to present at ... Fargo Healthcare Conference in BostonDate: , Thursday, ... Bank of America Merrill Lynch Global Healthcare ...
(Date:9/3/2015)... Research and Markets( http://www.researchandmarkets.com/research/fw4ctl/investigation ) has ... China,s Entecavir Market, 2010-2019" report to their offering. ... B virus (HBV) exceeds 100 million in ... chronic Hepatitis B. About 0.5 million Chinese is estimated ... by chronic Hepatitis B, causing a loss of over ...
(Date:9/3/2015)... CITY, Calif. , Sept. 3, 2015  Abaxis, ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Taylor , chief financial officer, will present at the ... 2015 on Thursday, September 10, 2015 at 11:00 a.m. ... Berkshire Place Hotel in New York City ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2China Entecavir Market Report 2010-2019 2
... -- Precision Antibody™ announced today its selection by the United ... to influenza virus antigens for both Influenza A and B. ... develop new vaccine potency assays. The term of the monoclonal ... the option of five additional years. On ...
... Robertson Global Health Solutions Corporation (OTCBB: RHSC) and ... they have signed a commercial agreement with Telemedicine Africa ... and solutions to the medically underserved population of Africa ... and Telemedicine Africa aim to deliver RHealth Advisor mobile ...
Cached Medicine Technology:FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 2FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 2Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 3Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa 4
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, ... leading national healthcare solutions organization, to provide electronic medical record (EMR) consulting services ... Amerinet members will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom ...
(Date:9/3/2015)... ... September 03, 2015 , ... BedJet released a new version of its award ... Kickstarter. Today the BedJet v2 pre-order campaign blazed past the $1 million ... campaigns ever on crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Companies to Watch for 2015 by economic development group GrowFL and the ... companies in the state selected for this prestigious award, which recognizes growing second-stage ...
(Date:9/3/2015)... ... 03, 2015 , ... The first part of a two-part investigative news segment ... filter lawsuits filed against Bard.** These lawsuits, filed by persons and the family ... or failed, have recently been consolidated for pretrial proceedings as multidistrict litigation, MDL 2641 ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
Breaking Medicine News(10 mins):Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... ... that special woman who has everything? Why stem cells, of course! Celebrity Beauty Engineer® ... how to look and feel their best! , ... (PRWEB) December 16, 2009 -- The holidays are rapidly approaching and what ...
... , WASHINGTON, Dec. 15 ... prescription drugs to cut costs, much less the more effective direct ... how big industry controls the health reform debate, according Consumer Watchdog. ... relatively modest proposal, far from President Obama,s campaign pledge to allow ...
... WASHINGTON, Dec. 15 The Food and Health Bureau has invited ... developing private hospitals at four sites in the Hong Kong Special ... , At a press conference, the Secretary for Food and ... was one of the initiatives under healthcare reform and a major ...
... , WASHINGTON, Dec. 15 Our Lady of Lourdes ... Jersey hospitals, has agreed to pay the United States $7.95 ... Justice Department announced today. The two hospitals are Our Lady ... Medical Center of Burlington County (LMC) in Willingboro, N.J. ...
... would have really been in trouble, expert says , TUESDAY, ... H1N1 swine flu has revealed serious flaws in the nation,s ... says. , The report, prepared by the Trust for America,s ... dire economy has strained the already underfunded public health system. ...
... , , ... the fight against malaria , Project developed with support ... , WASHINGTON, Dec. 15 ONE and Malaria ... "Malaria Griots" program, a dynamic education course that will train and ...
Cached Medicine News:Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: